aluates Reports

$ 0.0

Automative

Global Long-acting PrEP Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-14Z18527

BUY CHAPTERS

Global Long-acting PrEP Market Research Report 2024

Code: QYRE-Auto-14Z18527

Report

October 2024

Pages:68

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Gilead Sciences

ViiV Healthcare

Long-acting PrEP Market

Long-acting PrEP refers to HIV prevention strategies that involve the use of long-acting antiretroviral medications, administered less frequently than daily oral PrEP. Long-acting PrEP is designed to provide prolonged protection against HIV, improving adherence by reducing the need for daily pills and offering more flexibility for users.

The global Long-acting PrEP market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Long-acting PrEP is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Long-acting PrEP is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Long-acting PrEP include Gilead Sciences, ViiV Healthcare, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Long-acting PrEP, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Long-acting PrEP.

The Long-acting PrEP market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Long-acting PrEP market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Long-acting PrEP manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Long-acting PrEP Market Report

Report Metric	Details
Report Name	Long-acting PrEP Market
Segment by Type	Cabotegravir Lenacapavir Other
Segment by Application	Hospital Clinic Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Gilead Sciences, ViiV Healthcare
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Long-acting PrEP manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Long-acting PrEP in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Long-acting PrEP Market report?

Ans: The main players in the Long-acting PrEP Market are Gilead Sciences, ViiV Healthcare

What are the Application segmentation covered in the Long-acting PrEP Market report?

Ans: The Applications covered in the Long-acting PrEP Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Long-acting PrEP Market report?

Ans: The Types covered in the Long-acting PrEP Market report are Cabotegravir, Lenacapavir, Other

Recommended Reports

HIV Therapeutics

PrEP & Prevention

Preparation Kits

1 Long-acting PrEP Market Overview

1.1 Product Definition

1.2 Long-acting PrEP by Type

1.2.1 Global Long-acting PrEP Market Value Comparison by Type (2024-2030)

1.2.2 Cabotegravir

1.2.3 Lenacapavir

1.2.4 Other

1.3 Long-acting PrEP by Application

1.3.1 Global Long-acting PrEP Market Value by Application (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Other

1.4 Global Long-acting PrEP Market Size Estimates and Forecasts

1.4.1 Global Long-acting PrEP Revenue 2019-2030

1.4.2 Global Long-acting PrEP Sales 2019-2030

1.4.3 Global Long-acting PrEP Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Long-acting PrEP Market Competition by Manufacturers

2.1 Global Long-acting PrEP Sales Market Share by Manufacturers (2019-2024)

2.2 Global Long-acting PrEP Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Long-acting PrEP Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Long-acting PrEP, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Long-acting PrEP, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Long-acting PrEP, Product Type & Application

2.7 Global Key Manufacturers of Long-acting PrEP, Date of Enter into This Industry

2.8 Global Long-acting PrEP Market Competitive Situation and Trends

2.8.1 Global Long-acting PrEP Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Long-acting PrEP Players Market Share by Revenue

2.8.3 Global Long-acting PrEP Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Long-acting PrEP Market Scenario by Region

3.1 Global Long-acting PrEP Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Long-acting PrEP Sales by Region: 2019-2030

3.2.1 Global Long-acting PrEP Sales by Region: 2019-2024

3.2.2 Global Long-acting PrEP Sales by Region: 2025-2030

3.3 Global Long-acting PrEP Revenue by Region: 2019-2030

3.3.1 Global Long-acting PrEP Revenue by Region: 2019-2024

3.3.2 Global Long-acting PrEP Revenue by Region: 2025-2030

3.4 North America Long-acting PrEP Market Facts & Figures by Country

3.4.1 North America Long-acting PrEP Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Long-acting PrEP Sales by Country (2019-2030)

3.4.3 North America Long-acting PrEP Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Long-acting PrEP Market Facts & Figures by Country

3.5.1 Europe Long-acting PrEP Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Long-acting PrEP Sales by Country (2019-2030)

3.5.3 Europe Long-acting PrEP Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Long-acting PrEP Market Facts & Figures by Region

3.6.1 Asia Pacific Long-acting PrEP Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Long-acting PrEP Sales by Region (2019-2030)

3.6.3 Asia Pacific Long-acting PrEP Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Long-acting PrEP Market Facts & Figures by Country

3.7.1 Latin America Long-acting PrEP Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Long-acting PrEP Sales by Country (2019-2030)

3.7.3 Latin America Long-acting PrEP Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Long-acting PrEP Market Facts & Figures by Country

3.8.1 Middle East and Africa Long-acting PrEP Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Long-acting PrEP Sales by Country (2019-2030)

3.8.3 Middle East and Africa Long-acting PrEP Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Long-acting PrEP Sales by Type (2019-2030)

4.1.1 Global Long-acting PrEP Sales by Type (2019-2024)

4.1.2 Global Long-acting PrEP Sales by Type (2025-2030)

4.1.3 Global Long-acting PrEP Sales Market Share by Type (2019-2030)

4.2 Global Long-acting PrEP Revenue by Type (2019-2030)

4.2.1 Global Long-acting PrEP Revenue by Type (2019-2024)

4.2.2 Global Long-acting PrEP Revenue by Type (2025-2030)

4.2.3 Global Long-acting PrEP Revenue Market Share by Type (2019-2030)

4.3 Global Long-acting PrEP Price by Type (2019-2030)

5 Segment by Application

5.1 Global Long-acting PrEP Sales by Application (2019-2030)

5.1.1 Global Long-acting PrEP Sales by Application (2019-2024)

5.1.2 Global Long-acting PrEP Sales by Application (2025-2030)

5.1.3 Global Long-acting PrEP Sales Market Share by Application (2019-2030)

5.2 Global Long-acting PrEP Revenue by Application (2019-2030)

5.2.1 Global Long-acting PrEP Revenue by Application (2019-2024)

5.2.2 Global Long-acting PrEP Revenue by Application (2025-2030)

5.2.3 Global Long-acting PrEP Revenue Market Share by Application (2019-2030)

5.3 Global Long-acting PrEP Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Gilead Sciences

6.1.1 Gilead Sciences Company Information

6.1.2 Gilead Sciences Description and Business Overview

6.1.3 Gilead Sciences Long-acting PrEP Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Gilead Sciences Long-acting PrEP Product Portfolio

6.1.5 Gilead Sciences Recent Developments/Updates

6.2 ViiV Healthcare

6.2.1 ViiV Healthcare Company Information

6.2.2 ViiV Healthcare Description and Business Overview

6.2.3 ViiV Healthcare Long-acting PrEP Sales, Revenue and Gross Margin (2019-2024)

6.2.4 ViiV Healthcare Long-acting PrEP Product Portfolio

6.2.5 ViiV Healthcare Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Long-acting PrEP Industry Chain Analysis

7.2 Long-acting PrEP Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Long-acting PrEP Production Mode & Process

7.4 Long-acting PrEP Sales and Marketing

7.4.1 Long-acting PrEP Sales Channels

7.4.2 Long-acting PrEP Distributors

7.5 Long-acting PrEP Customers

8 Long-acting PrEP Market Dynamics

8.1 Long-acting PrEP Industry Trends

8.2 Long-acting PrEP Market Drivers

8.3 Long-acting PrEP Market Challenges

8.4 Long-acting PrEP Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Gilead Sciences

ViiV Healthcare

List of Tables

Table 1. Global Long-acting PrEP Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Long-acting PrEP Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Long-acting PrEP Market Competitive Situation by Manufacturers in 2023

Table 4. Global Long-acting PrEP Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Long-acting PrEP Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Long-acting PrEP Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Long-acting PrEP Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Long-acting PrEP Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Long-acting PrEP, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Long-acting PrEP, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Long-acting PrEP, Product Type & Application

Table 12. Global Key Manufacturers of Long-acting PrEP, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Long-acting PrEP by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting PrEP as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Long-acting PrEP Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Long-acting PrEP Sales by Region (2019-2024) & (K Units)

Table 18. Global Long-acting PrEP Sales Market Share by Region (2019-2024)

Table 19. Global Long-acting PrEP Sales by Region (2025-2030) & (K Units)

Table 20. Global Long-acting PrEP Sales Market Share by Region (2025-2030)

Table 21. Global Long-acting PrEP Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Long-acting PrEP Revenue Market Share by Region (2019-2024)

Table 23. Global Long-acting PrEP Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Long-acting PrEP Revenue Market Share by Region (2025-2030)

Table 25. North America Long-acting PrEP Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Long-acting PrEP Sales by Country (2019-2024) & (K Units)

Table 27. North America Long-acting PrEP Sales by Country (2025-2030) & (K Units)

Table 28. North America Long-acting PrEP Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Long-acting PrEP Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Long-acting PrEP Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Long-acting PrEP Sales by Country (2019-2024) & (K Units)

Table 32. Europe Long-acting PrEP Sales by Country (2025-2030) & (K Units)

Table 33. Europe Long-acting PrEP Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Long-acting PrEP Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Long-acting PrEP Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Long-acting PrEP Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Long-acting PrEP Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Long-acting PrEP Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Long-acting PrEP Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Long-acting PrEP Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Long-acting PrEP Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Long-acting PrEP Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Long-acting PrEP Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Long-acting PrEP Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Long-acting PrEP Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Long-acting PrEP Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Long-acting PrEP Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Long-acting PrEP Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Long-acting PrEP Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Long-acting PrEP Sales (K Units) by Type (2019-2024)

Table 51. Global Long-acting PrEP Sales (K Units) by Type (2025-2030)

Table 52. Global Long-acting PrEP Sales Market Share by Type (2019-2024)

Table 53. Global Long-acting PrEP Sales Market Share by Type (2025-2030)

Table 54. Global Long-acting PrEP Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Long-acting PrEP Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Long-acting PrEP Revenue Market Share by Type (2019-2024)

Table 57. Global Long-acting PrEP Revenue Market Share by Type (2025-2030)

Table 58. Global Long-acting PrEP Price (US$/Unit) by Type (2019-2024)

Table 59. Global Long-acting PrEP Price (US$/Unit) by Type (2025-2030)

Table 60. Global Long-acting PrEP Sales (K Units) by Application (2019-2024)

Table 61. Global Long-acting PrEP Sales (K Units) by Application (2025-2030)

Table 62. Global Long-acting PrEP Sales Market Share by Application (2019-2024)

Table 63. Global Long-acting PrEP Sales Market Share by Application (2025-2030)

Table 64. Global Long-acting PrEP Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Long-acting PrEP Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Long-acting PrEP Revenue Market Share by Application (2019-2024)

Table 67. Global Long-acting PrEP Revenue Market Share by Application (2025-2030)

Table 68. Global Long-acting PrEP Price (US$/Unit) by Application (2019-2024)

Table 69. Global Long-acting PrEP Price (US$/Unit) by Application (2025-2030)

Table 70. Gilead Sciences Company Information

Table 71. Gilead Sciences Description and Business Overview

Table 72. Gilead Sciences Long-acting PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Gilead Sciences Long-acting PrEP Product

Table 74. Gilead Sciences Recent Developments/Updates

Table 75. ViiV Healthcare Company Information

Table 76. ViiV Healthcare Description and Business Overview

Table 77. ViiV Healthcare Long-acting PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. ViiV Healthcare Long-acting PrEP Product

Table 79. ViiV Healthcare Recent Developments/Updates

Table 80. Key Raw Materials Lists

Table 81. Raw Materials Key Suppliers Lists

Table 82. Long-acting PrEP Distributors List

Table 83. Long-acting PrEP Customers List

Table 84. Long-acting PrEP Market Trends

Table 85. Long-acting PrEP Market Drivers

Table 86. Long-acting PrEP Market Challenges

Table 87. Long-acting PrEP Market Restraints

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Product Picture of Long-acting PrEP

Figure 2. Global Long-acting PrEP Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Long-acting PrEP Market Share by Type: 2023 & 2030

Figure 4. Cabotegravir Product Picture

Figure 5. Lenacapavir Product Picture

Figure 6. Other Product Picture

Figure 7. Global Long-acting PrEP Market Value by Application (2024-2030) & (US$ Million)

Figure 8. Global Long-acting PrEP Market Share by Application: 2023 & 2030

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Other

Figure 12. Global Long-acting PrEP Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Long-acting PrEP Market Size (2019-2030) & (US$ Million)

Figure 14. Global Long-acting PrEP Sales (2019-2030) & (K Units)

Figure 15. Global Long-acting PrEP Average Price (US$/Unit) & (2019-2030)

Figure 16. Long-acting PrEP Report Years Considered

Figure 17. Long-acting PrEP Sales Share by Manufacturers in 2023

Figure 18. Global Long-acting PrEP Revenue Share by Manufacturers in 2023

Figure 19. Global 5 and 10 Largest Long-acting PrEP Players: Market Share by Revenue in Long-acting PrEP in 2023

Figure 20. Long-acting PrEP Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 21. Global Long-acting PrEP Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Long-acting PrEP Sales Market Share by Country (2019-2030)

Figure 23. North America Long-acting PrEP Revenue Market Share by Country (2019-2030)

Figure 24. United States Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Long-acting PrEP Sales Market Share by Country (2019-2030)

Figure 27. Europe Long-acting PrEP Revenue Market Share by Country (2019-2030)

Figure 28. Germany Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Long-acting PrEP Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Long-acting PrEP Revenue Market Share by Region (2019-2030)

Figure 35. China Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Southeast Asia Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Latin America Long-acting PrEP Sales Market Share by Country (2019-2030)

Figure 43. Mexico Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Colombia Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Middle East and Africa Long-acting PrEP Sales Market Share by Country (2019-2030)

Figure 48. Middle East and Africa Long-acting PrEP Revenue Market Share by Country (2019-2030)

Figure 49. Turkey Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Saudi Arabia Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. UAE Long-acting PrEP Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Global Sales Market Share of Long-acting PrEP by Type (2019-2030)

Figure 53. Global Revenue Market Share of Long-acting PrEP by Type (2019-2030)

Figure 54. Global Long-acting PrEP Price (US$/Unit) by Type (2019-2030)

Figure 55. Global Sales Market Share of Long-acting PrEP by Application (2019-2030)

Figure 56. Global Revenue Market Share of Long-acting PrEP by Application (2019-2030)

Figure 57. Global Long-acting PrEP Price (US$/Unit) by Application (2019-2030)

Figure 58. Long-acting PrEP Value Chain

Figure 59. Long-acting PrEP Production Process

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Parenteral PrEP Market Research Report 2024

Global Drugs for PrEP Market Research Report 2024

Global Pre Exposure Prophylaxis PrEP Market Research Report 2024

Global Injectable HIV Medication Market Research Report 2024

Pre Exposure Prophylaxis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long acting Anti HIV Drug Market Research Report 2024

Global Injectable HIV Treatment Market Research Report 2024

Global Long Acting Contraceptive Pills Market Research Report 2024

Global Long acting Peginterferon Market Research Report 2024

Global Long acting Weight Loss Drugs Market Research Report 2024

Global HIV Therapy Market Research Report 2025

Long acting Injectable Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antiretroviral Protease Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global HIV Prevention Drug Market Research Report 2024

HIV Antiretroviral Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sustained Release Injectables Market Research Report 2024

Global Long acting EPO Drugs Market Research Report 2024

Global Long Acting Reversible Contraception LARC Market Research Report 2024

Global Antiretroviral Agent Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21N6899

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13M6952

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-29X7355

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-28B293

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Long-acting PrEP Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-14Z18527

Global Long-acting PrEP Market Research Report 2024

FEATURED COMPANIES

Long-acting PrEP Market

Report Scope

Scope of Long-acting PrEP Market Report

Core Chapters

FAQ for this report

Who are the main players in the Long-acting PrEP Market report?

What are the Application segmentation covered in the Long-acting PrEP Market report?

What are the Type segmentation covered in the Long-acting PrEP Market report?

Recommended Reports

HIV Therapeutics

PrEP & Prevention

Preparation Kits

FEATURED COMPANIES

RELATED REPORTS